Edition:
India

DaVita Inc (DVA.N)

DVA.N on New York Stock Exchange

78.61USD
19 Jan 2018
Change (% chg)

$0.42 (+0.54%)
Prev Close
$78.19
Open
$78.18
Day's High
$78.73
Day's Low
$77.74
Volume
343,426
Avg. Vol
583,908
52-wk High
$80.70
52-wk Low
$52.52

Latest Key Developments (Source: Significant Developments)

UnitedHealth's Optum To Buy Davita Medical Group For About $4.9 Bln In Cash
Wednesday, 6 Dec 2017 

Dec 6 (Reuters) - UnitedHealth Group Inc ::DAVITA MEDICAL GROUP TO JOIN OPTUM.OPTUM - ‍AGREEMENT, ENTERED INTO ON DECEMBER 5, 2017, CALLS FOR OPTUM TO ACQUIRE DAVITA MEDICAL GROUP FOR APPROXIMATELY $4.9 BILLION IN CASH​.OPTUM - FOLLOWING TRANSACTION, DAVITA MEDICAL GROUP WILL BECOME PART OF OPTUM'S OPTUMCARE DIVISION.OPTUM - ‍DAVITA PLANS TO USE PROCEEDS FROM DEAL FOR SIGNIFICANT STOCK REPURCHASES OVER 1 TO 2 YRS AFTER CLOSE OF DEAL, AS WELL AS TO REPAY DEBT​, OTHERS.OPTUM - ‍JOE MELLO, COO OF DAVITA MEDICAL GROUP, WILL CONTINUE IN LEADERSHIP ROLE IN COMBINED ENTITY, AS WILL DAVITA MEDICAL GROUP LEADERSHIP TEAM​.  Full Article

DaVita Medical Group Acquires Large IPA Network In The Pacific Northwest
Wednesday, 29 Nov 2017 

Nov 28 (Reuters) - DaVita Inc ::DAVITA MEDICAL GROUP ACQUIRES LARGE IPA NETWORK IN THE PACIFIC NORTHWEST.DAVITA MEDICAL GROUP - ANNOUNCED ACQUISITION OF NORTHWEST PHYSICIANS NETWORK.  Full Article

Davita says recognizes that DMG business is not achieving capital return expectations - conf call ‍​
Wednesday, 8 Nov 2017 

Nov 7 (Reuters) - DaVita Inc ::DaVita CFO, on conf call, says we recognize that the DaVita Medical Group business is not achieving our capital return expectations ‍​.  Full Article

DaVita Inc. 3rd quarter 2017 results
Wednesday, 8 Nov 2017 

Nov 7 (Reuters) - Davita Inc :DaVita Inc. 3rd quarter 2017 results.Q3 loss per share $1.14.Q3 earnings per share view $0.94 -- Thomson Reuters I/B/E/S.Q3 adjusted earnings per share $0.81.DaVita Inc - ‍adjusted consolidated operating income guidance for 2017 to be in range of $1.62 billion to $1.69 billion​.DaVita -‍total U.S. Dialysis treatments for Q3 2017 were 7.2 million or 90,966 treatments per day, representing a per day increase of 4.3% over Q3 2016​.DaVita Inc qtrly total net revenues $3.92 billion versus $3.73 billion.Q3 revenue view $3.90 billion -- Thomson Reuters I/B/E/S.  Full Article

DaVita provides additional information regarding patients receiving charitable premium assistance
Monday, 16 Oct 2017 

Oct 16 (Reuters) - DaVita Inc :DaVita provides additional information regarding patients receiving charitable premium assistance.DaVita - If charitable assistance not available to patients,co estimates impact to annual operating income after cost offsets, $100 million - $250 million​.  Full Article

Davita Inc increases share repurchase program to $1.5 bln
Wednesday, 11 Oct 2017 

Oct 10 (Reuters) - Davita Inc :Davita Inc - ‍on October 10, board increased authorization under co's share repurchase program to aggregate of $1.5 billion in repurchasing authority​.Davita says ‍existing repurchase program, new repurchase program do not have expiration date, do not obligate co to purchase any shares - SEC filing.  Full Article

Davita provides disclosures regarding charitable premium assistance
Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - Davita Inc :Davita provides disclosures regarding charitable premium assistance.Davita - ‍loss of individual coverage for patients without charitable premium assistance could reduce expected annual operating income by $45 million - $90 million​.  Full Article

U.S. FTC says approves final order settling charges related to DaVita-Renal Ventures deal
Wednesday, 14 Jun 2017 

June 14 (Reuters) - U.S. Federal Trade Commission::Approved final order settling charges that DaVita Inc’s acquisition of Renal Ventures Management would have been anticompetitive.  Full Article

Davita Healthcare posts Q2 adj. earnings per share $1.01
Tuesday, 9 Aug 2016 

Davita Healthcare Partners Inc : Davita Healthcare Partners Inc 2nd quarter 2016 results . Q2 earnings per share $0.26 including items . Q2 adjusted earnings per share $1.01 excluding items . Q2 earnings per share view $0.98 -- Thomson Reuters I/B/E/S . Updating operating income guidance for kidney care for 2016 to be in range of $1.675 billion to $1.725 billion . Updating adjusted consolidated operating income guidance for 2016 to be in range of $1.785 billion to $1.875 billion . Total U.S. dialysis treatments for Q2 2016 6,745,610, or 86,482 treatments per day,reprenting/day increase of 4.4 pct over Q2 of 2015 .Davita Healthcare Partners Inc says updating consolidated operating cash flow for 2016 to be in range of $1.600 billion to $1.750 billion.  Full Article

Davita announces intent to enter into transaction with Inspira Health Network to provide dialysis services
Wednesday, 8 Jun 2016 

Davita Healthcare Partners Inc : Davita announces intent to enter into transaction with Inspira Health Network to provide dialysis services . Financial terms were not disclosed. .To enter into a joint venture acquisition with Inspira Health Network that will bring Davita's patient care to Southern New Jersey.  Full Article

BRIEF-Davita Kidney Care Issues Statement About Davita Rx Settlement

* DAVITA KIDNEY CARE ISSUES STATEMENT ABOUT DAVITA RX SETTLEMENT